Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes.
This report aims to provide a comprehensive presentation of the global market for Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs. This report contains market size and forecasts of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in global, including the following market information:
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Sales, 2018-2023, 2024-2030, (K MT)
Global top five Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs companies in 2022 (%)
The global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising markets in the upcoming period.
We surveyed the Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment Percentages, by Type, 2022 (%)
Macular Degeneration Drugs
Diabetic Retinopathy Drugs
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment Percentages, by Application, 2022 (%)
50-60 Years Old
60-70 Years Old
Others
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs revenues share in global market, 2022 (%)
Key companies Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Bayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs, market overview.
Chapter 2: Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Overall Market Size
2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size: 2022 VS 2030
2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in Global Market
3.2 Top Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies Ranked by Revenue
3.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Companies
3.4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Companies
3.5 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Markets, 2022 & 2030
4.1.2 Macular Degeneration Drugs
4.1.3 Diabetic Retinopathy Drugs
4.2 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue & Forecasts
4.2.1 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2024-2030
4.2.3 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales & Forecasts
4.3.1 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2018-2023
4.3.2 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2024-2030
4.3.3 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2022 & 2030
5.1.2 50-60 Years Old
5.1.3 60-70 Years Old
5.1.4 Others
5.2 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue & Forecasts
5.2.1 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2024-2030
5.2.3 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales & Forecasts
5.3.1 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2018-2023
5.3.2 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2024-2030
5.3.3 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2022 & 2030
6.2 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue & Forecasts
6.2.1 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2024-2030
6.2.3 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales & Forecasts
6.3.1 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2018-2023
6.3.2 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2024-2030
6.3.3 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2018-2030
6.4.2 By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2018-2030
6.4.3 US Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.4.4 Canada Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.4.5 Mexico Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2018-2030
6.5.3 Germany Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.5.4 France Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.5.5 U.K. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.5.6 Italy Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.5.7 Russia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.5.9 Benelux Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2018-2030
6.6.3 China Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.6.4 Japan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.6.5 South Korea Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.6.7 India Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2018-2030
6.7.2 By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2018-2030
6.7.3 Brazil Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.7.4 Argentina Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2018-2030
6.8.3 Turkey Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.8.4 Israel Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
6.8.6 UAE Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.1.4 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Company Summary
7.2.2 Bayer Healthcare Business Overview
7.2.3 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.2.4 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Bayer Healthcare Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.3.4 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Neurotech Pharmaceuticals
7.4.1 Neurotech Pharmaceuticals Company Summary
7.4.2 Neurotech Pharmaceuticals Business Overview
7.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Neurotech Pharmaceuticals Key News & Latest Developments
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Company Summary
7.5.2 Regeneron Pharmaceuticals Business Overview
7.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.6 Allergan
7.6.1 Allergan Company Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.6.4 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Allergan Key News & Latest Developments
8 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity, Analysis
8.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity, 2018-2030
8.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Supply Chain Analysis
10.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Value Chain
10.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Upstream Market
10.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in Global Market
Table 2. Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Companies, (K MT), 2018-2023
Table 6. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type
Table 9. List of Global Tier 1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2018-2023
Table 15. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2024-2030
Table 16. By Application ? Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2018-2023
Table 20. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2024-2030
Table 21. By Region ? Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2018-2023
Table 25. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2024-2030
Table 26. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2018-2023
Table 29. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2024-2030
Table 30. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2018-2023
Table 33. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2024-2030
Table 34. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2018-2023
Table 37. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2024-2030
Table 38. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2018-2023
Table 41. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2024-2030
Table 42. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2024-2030
Table 46. Novartis Company Summary
Table 47. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 48. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Bayer Healthcare Company Summary
Table 51. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 52. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Bayer Healthcare Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 56. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Neurotech Pharmaceuticals Company Summary
Table 59. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 60. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Neurotech Pharmaceuticals Key News & Latest Developments
Table 62. Regeneron Pharmaceuticals Company Summary
Table 63. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 64. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Regeneron Pharmaceuticals Key News & Latest Developments
Table 66. Allergan Company Summary
Table 67. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 68. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Allergan Key News & Latest Developments
Table 70. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 71. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production by Region, 2018-2023 (K MT)
Table 73. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production by Region, 2024-2030 (K MT)
Table 74. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Opportunities & Trends in Global Market
Table 75. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Drivers in Global Market
Table 76. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Restraints in Global Market
Table 77. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Raw Materials
Table 78. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Raw Materials Suppliers in Global Market
Table 79. Typical Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Downstream
Table 80. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Downstream Clients in Global Market
Table 81. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segment by Type in 2022
Figure 2. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segment by Application in 2022
Figure 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Global Market: 2018-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue in 2022
Figure 9. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (USD/MT), 2018-2030
Figure 13. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (USD/MT), 2018-2030
Figure 17. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
Figure 23. US Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
Figure 28. Germany Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
Figure 37. China Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity (K MT), 2018-2030
Figure 53. The Percentage of Production Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Region, 2022 VS 2030
Figure 54. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Value Chain
Figure 55. Marketing Channels
